Summary:
This is a safety, tolerability and pharmacokinetic study in subjects with Parkinson's disease
Qualified Participants Must:
Have Parkinson's Disease
Be 18 to 65 years old
Qualified Participants May Receive:
Compensation for time and travel, may receive investigational medication or placebo.